| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 9.864 | 14.653 | 5.755 | 3.359 | 6.419 | 5.579 | 8.182 | 10.521 | 15.573 | 7.543 |
| Total Income - EUR | 10.965 | 14.885 | 5.755 | 4.164 | 6.419 | 6.653 | 8.182 | 10.521 | 15.573 | 7.543 |
| Total Expenses - EUR | 10.626 | 14.589 | 13.258 | 8.144 | 6.562 | 8.671 | 11.960 | 10.544 | 16.467 | 7.909 |
| Gross Profit/Loss - EUR | 339 | 296 | -7.503 | -3.981 | -143 | -2.018 | -3.778 | -23 | -894 | -366 |
| Net Profit/Loss - EUR | 16 | 134 | -7.547 | -4.027 | -182 | -2.057 | -3.778 | -77 | -1.049 | -481 |
| Employees | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 |
Check the financial reports for the company - Evlyne Bio Spa Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.012 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 2.439 | 5.422 | 991 | 1.410 | 1.267 | 1.748 | -53 | 1.621 | 1.510 | 727 |
| Inventories | 636 | 0 | 0 | 142 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 82 | 0 | 0 | 3 | 111 | 43 | 17 | 1.212 | 0 | 0 |
| Cash | 1.721 | 5.422 | 991 | 1.264 | 1.156 | 1.705 | -70 | 409 | 1.510 | 727 |
| Shareholders Funds | 2.283 | 2.394 | -5.193 | -9.125 | -9.131 | -11.014 | -14.552 | -14.674 | -15.679 | -16.072 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.168 | 3.028 | 6.185 | 10.535 | 10.397 | 12.762 | 14.498 | 16.295 | 17.188 | 16.799 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "9622 - 9622" | |||||||||
| CAEN Financial Year |
9604
|
|||||||||
Comments - Evlyne Bio Spa Srl